Browsing by Author "Ricciardi, Angelo"

Now showing items 1-5 of 5

    • Cannabidiol (CBD) Use in Psychiatric Disorders; A Systematic Review 

      Bonaccorso, Stefania; Ricciardi, Angelo; Zangani, Caroline; Chiappini, Stefania; Schifano, Fabrizio (2019-09)
      Cannabidiol (CBD) and ∆9-tetrahydrocannabinol (THC) are the most represented phytocannabinoids in Cannabis sativa plants. However, CBD may present with a different activity compared with the psychotomimetic THC. Most ...

    • Clozapine, neutropenia and Covid-19: should clinicians be concerned? 3 months report 

      Bonaccorso, Stefania; Ricciardi, Angelo; Ouabbou, Sophie; Theleritis, Christos; Ross-Michealides, Arabella; Metastasio, Antonio; Stewart, Neil; Mohammed, Marwa; Schifano, Fabrizio (2021-05)
      Background: Clozapine is among the most effective antipsychotics used for treatment resistant schizophrenia. Adverse reactions to clozapine include neutropenia. In March 2020, at the start of the Coronavirus -19 pandemic, ...

    • New psychoactive substances (NPS), psychedelic experiences, and dissociation: clinical and clinical pharmacological issues 

      Schifano, Fabrizio; Napoletano, Flavia; Chiappini, Stephania; Orsolini, Laura; Guirguis, Amira; Corkery, John Martin; Bonaccorso, Stefania; Ricciardi, Angelo; Scherbaum, Norbert; vento, alessandro (2019-04-23)
      Purpose of the review: A significant increase in the number, type, and availability of new psychoactive substances (NPS) with dissociative and psychedelic potential has occurred worldwide over the last few decades. Psychedelic ...

    • New/emerging psychoactive substances and associated psychopathological consequences 

      Schifano, Fabrizio; Napoletano, Flavia; Chiappini, Stephania; Guirguis, Amira; Corkery, John; Bonaccorso, Stefania; Ricciardi, Angelo; Scherbaum, Norbert; vento, alessandro (2019-07-22)
      BackgroundThe present paper provides an updated review of both the large number of new/novel/emerging psychoactive substances (NPS) and their associated psychopathological consequences. Focus was here given on identification ...

    • Synthetic cannabinoid use in a case series of patients with psychosis presenting to acute psychiatric settings : Clinical presentation and management issues 

      Bonaccorso, Stefania; Metastasio, Antonio; Ricciardi, Angelo; Stewart, Neil; Jamal, Leila; Rujully, Naasir Ud Dinn; Theleritis, Christos; Ferracuti, Stefano; Ducci, Giuseppe; Schifano, Fabrizio (2018-07-14)
      Background: Novel Psychoactive Substances (NPS) are a heterogeneous class of synthetic molecules including synthetic cannabinoid receptor agonists (SCRAs). Psychosis is associated with SCRAs use. There is limited knowledge ...